DongKook Pharmaceutical (Korea) Market Value

086450 Stock  KRW 15,170  30.00  0.20%   
DongKook Pharmaceutical's market value is the price at which a share of DongKook Pharmaceutical trades on a public exchange. It measures the collective expectations of DongKook Pharmaceutical Co investors about its performance. DongKook Pharmaceutical is trading at 15170.00 as of the 16th of March 2025, a 0.20 percent increase since the beginning of the trading day. The stock's open price was 15140.0.
With this module, you can estimate the performance of a buy and hold strategy of DongKook Pharmaceutical Co and determine expected loss or profit from investing in DongKook Pharmaceutical over a given investment horizon. Check out DongKook Pharmaceutical Correlation, DongKook Pharmaceutical Volatility and DongKook Pharmaceutical Alpha and Beta module to complement your research on DongKook Pharmaceutical.
Symbol

Please note, there is a significant difference between DongKook Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if DongKook Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DongKook Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

DongKook Pharmaceutical 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to DongKook Pharmaceutical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of DongKook Pharmaceutical.
0.00
12/16/2024
No Change 0.00  0.0 
In 2 months and 31 days
03/16/2025
0.00
If you would invest  0.00  in DongKook Pharmaceutical on December 16, 2024 and sell it all today you would earn a total of 0.00 from holding DongKook Pharmaceutical Co or generate 0.0% return on investment in DongKook Pharmaceutical over 90 days. DongKook Pharmaceutical is related to or competes with Samsung Electronics, Samsung Electronics, Hyundai, Hyundai, Hyundai, SK Holdings, and KB Financial. DongKook Pharmaceutical Co., Ltd. provides pharmaceutical products in South Korea and internationally More

DongKook Pharmaceutical Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure DongKook Pharmaceutical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess DongKook Pharmaceutical Co upside and downside potential and time the market with a certain degree of confidence.

DongKook Pharmaceutical Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for DongKook Pharmaceutical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as DongKook Pharmaceutical's standard deviation. In reality, there are many statistical measures that can use DongKook Pharmaceutical historical prices to predict the future DongKook Pharmaceutical's volatility.
Hype
Prediction
LowEstimatedHigh
15,16815,17015,172
Details
Intrinsic
Valuation
LowRealHigh
13,65315,33215,334
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as DongKook Pharmaceutical. Your research has to be compared to or analyzed against DongKook Pharmaceutical's peers to derive any actionable benefits. When done correctly, DongKook Pharmaceutical's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in DongKook Pharmaceutical.

DongKook Pharmaceutical Backtested Returns

DongKook Pharmaceutical secures Sharpe Ratio (or Efficiency) of -0.0763, which denotes the company had a -0.0763 % return per unit of risk over the last 3 months. DongKook Pharmaceutical Co exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm DongKook Pharmaceutical's Standard Deviation of 1.78, variance of 3.16, and Mean Deviation of 1.33 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.52, which means possible diversification benefits within a given portfolio. As returns on the market increase, DongKook Pharmaceutical's returns are expected to increase less than the market. However, during the bear market, the loss of holding DongKook Pharmaceutical is expected to be smaller as well. At this point, DongKook Pharmaceutical has a negative expected return of -0.13%. Please make sure to confirm DongKook Pharmaceutical's jensen alpha, treynor ratio, and the relationship between the standard deviation and total risk alpha , to decide if DongKook Pharmaceutical performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  -0.27  

Weak reverse predictability

DongKook Pharmaceutical Co has weak reverse predictability. Overlapping area represents the amount of predictability between DongKook Pharmaceutical time series from 16th of December 2024 to 30th of January 2025 and 30th of January 2025 to 16th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of DongKook Pharmaceutical price movement. The serial correlation of -0.27 indicates that nearly 27.0% of current DongKook Pharmaceutical price fluctuation can be explain by its past prices.
Correlation Coefficient-0.27
Spearman Rank Test-0.38
Residual Average0.0
Price Variance133.8 K

DongKook Pharmaceutical lagged returns against current returns

Autocorrelation, which is DongKook Pharmaceutical stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting DongKook Pharmaceutical's stock expected returns. We can calculate the autocorrelation of DongKook Pharmaceutical returns to help us make a trade decision. For example, suppose you find that DongKook Pharmaceutical has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

DongKook Pharmaceutical regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If DongKook Pharmaceutical stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if DongKook Pharmaceutical stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in DongKook Pharmaceutical stock over time.
   Current vs Lagged Prices   
       Timeline  

DongKook Pharmaceutical Lagged Returns

When evaluating DongKook Pharmaceutical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of DongKook Pharmaceutical stock have on its future price. DongKook Pharmaceutical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, DongKook Pharmaceutical autocorrelation shows the relationship between DongKook Pharmaceutical stock current value and its past values and can show if there is a momentum factor associated with investing in DongKook Pharmaceutical Co.
   Regressed Prices   
       Timeline  

Pair Trading with DongKook Pharmaceutical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DongKook Pharmaceutical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DongKook Pharmaceutical will appreciate offsetting losses from the drop in the long position's value.

Moving against DongKook Stock

  0.53336570 Daishin Balance No8PairCorr
The ability to find closely correlated positions to DongKook Pharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DongKook Pharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DongKook Pharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DongKook Pharmaceutical Co to buy it.
The correlation of DongKook Pharmaceutical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DongKook Pharmaceutical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DongKook Pharmaceutical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DongKook Pharmaceutical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in DongKook Stock

DongKook Pharmaceutical financial ratios help investors to determine whether DongKook Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DongKook with respect to the benefits of owning DongKook Pharmaceutical security.